FDA grants accelerated approval to new treatment for advanced ovarian cancer - FDA Press Releases

The U.S. Food and Drug Administration today granted accelerated approval to Rubraca (rucaparib) to treat women with a certain type of ovarian cancer.

from Food and Drug Administration--Press Releases http://ift.tt/2i1m66K
via IFTTT